AGP Executive Report
Last update: 10 hours agoMenopause & mental health: A University of Oulu study of 2,600 Finnish women links earlier-than-usual menopause transition with higher anxiety and depression symptoms. Child health & medicines: Kela and the University of Tampere report rising use of nervous-system medicines in Finnish children (up to 15.5% in 2025), with ADHD drugs increasing sharply while antibiotic use declines. Burnout at work: A Finnish Institute of Occupational Health study finds 26% of working Finns have elevated risk or severe burnout, pointing to bureaucracy, role conflicts, and workplace friction. Nursing retention: Research from Saudi Arabia suggests nurses’ intention to quit is driven more by organizational commitment than by the physical work environment. Healthcare funding & youth services: The EU Commission approved Finland’s fifth RRF payment request (€229.2m), including support for youth centres with extra health, education and social professionals. New cancer trial in Finland: Orion Pharma says the first patient has been dosed in a Phase 1/2 trial of ODM-216, a new biologic for advanced solid tumours. Antimicrobial resistance focus: An EU-led assessment mission to Albania will review AMR surveillance, lab capacity, stewardship, and infection control across human and animal health.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
